BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 17, 2015
View Archived Issues
Combination of three approved beta-lactams kills MRSA
Read More
Idera Pharmaceuticals begins phase I/II trial of intratumoral IMO-2125
Read More
Solgenix initiates pivotal phase III study of SGX-301 for CTCL
Read More
FDA grants orphan drug designation to AAV9-IDS for the treatment of MPS type II
Read More
Nemucore Medical Innovations forms licensing agreement with Pfenex
Read More
Poxel confirms start of phase IIb study in Japan
Read More
Attempts to model ALS in transgenic mice expressing C9orf72 containing hexanucleotide repeats
Read More
Carmot and Sunesis present PDK1 inhibitors
Read More
Lilly reports AMPA receptor antagonists
Read More
Medivation introduces bromodomain-containing protein inhibitors
Read More
BET inhibitor from Zenith Epigenetics shows efficacy in preclinical studies
Read More
PI3Kgamma inhibitor BVD-723 shows activity in murine models of cancer
Read More
Probody drug conjugate targeting CD166 shows promise for the treatment of cancer
Read More
CC-31244 shows potent anti-HCV activity
Read More
Sanofi and Boehringer Ingelheim propose exchange of business units
Read More
GBT-1118 improves hypoxia survival in mice
Read More
Novartis patents nonsense mutation suppressors
Read More
Universidad de Granada and Universita degli Studi di Padova disclose choline kinase inhibitors
Read More
Pharmakea announces USP9X inhibitors
Read More
Taiho Pharmaceutical reports AR antagonists
Read More
DNDi criticizes KaloBios plan to register benznidazole for Chagas disease in the U.S.
Read More
Arch Therapeutics reports preclinical data for hemostatic; cleared to start clinical trial in Europe
Read More
Validus acquires U.S. rights to several launched products from Sanofi
Read More
AstraZeneca forms strategic alliance with WuXi AppTec and expands Chinese operations
Read More
AstraZeneca acquires majority stake in Acerta Pharma
Read More
Viekirax filed for additional indication in Japan
Read More
FDA accepts BLA for PaxVax's oral cholera vaccine Vaxchora
Read More
FDA lifts clinical hold on Advaxis cancer vaccines
Read More
Galapagos and Gilead Sciences partner to develop filgotinib for inflammatory diseases
Read More
FDA grants fast track designation to ibudilast for ALS
Read More